No Data
No Data
DaShenLin Pharmaceutical Group's (SHSE:603233) Conservative Accounting Might Explain Soft Earnings
DaShenLin Pharmaceutical Group Co., Ltd. Just Recorded A 30% EPS Beat: Here's What Analysts Are Forecasting Next
These 4 Measures Indicate That DaShenLin Pharmaceutical Group (SHSE:603233) Is Using Debt Reasonably Well
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the main operating data for the first quarter of 2025
Dashenlin Pharmaceutical Group Co., Ltd. Report for the first quarter of 2025
Dashenlin Pharmaceutical Group Co., Ltd. 2024 Annual Report